Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 DiabetesA Randomized Controlled Trial
Top Cited Papers
Open Access
- 12 November 2008
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 300 (18) , 2134-2141
- https://doi.org/10.1001/jama.2008.623
Abstract
Diabetes mellitus is a powerful risk factor for cardiovascular events. The Framingham Heart Study reported that diabetes was associated with odds ratios for coronary heart disease of 1.5 and 1.8 for men and women, respectively, and relative risks for stroke of 1.4 and 1.7 for men and women, respectively.1-5 Individuals with diabetes have a 2- to 4-fold increased risk of developing cardiovascular events than those without diabetes.6Keywords
This publication has 18 references indexed in Scilit:
- The benefit of aspirin therapy in type 2 diabetes: What is the evidence?International Journal of Cardiology, 2008
- Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)Revista Española de Cardiología (English Edition), 2007
- Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic PatientsDiabetes Care, 2003
- Profile for Estimating Risk of Heart FailureArchives of internal medicine (1960), 1999
- Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.Diabetes Care, 1999
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998
- Diabetes and Cardiovascular Disease in a Prospective Population Survey in Japan: The Hisayama StudyDiabetes, 1996
- Probability of stroke: a risk profile from the Framingham Study.Stroke, 1991
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979
- Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham StudyDiabetes Care, 1979